Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 15, 2022
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
[ Wed, Jun 15th 2022
] - WOPRAI
Tue, June 14, 2022
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
Michael Ulz Maintained (BPMC) at Hold with Decreased Target to $65 on, Jun 14th, 2022
Michael Ulz of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Decreased Target from $92 to $65 on, Jun 14th, 2022.
Michael has made no other calls on BPMC in the last 4 months.
There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $60 on, Monday, June 13th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $65 on, Thursday, May 19th, 2022
These are the ratings of the 4 analyists that currently disagree with Michael
- David Lebowitz of "Citigroup" Downgraded from Hold to Strong Sell and Decreased Target to $41 on, Friday, June 10th, 2022
- Eun Yang of "Jefferies" Upgraded from Hold to Strong Buy and Decreased Target to $78 on, Wednesday, June 1st, 2022
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $105 on, Friday, March 4th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $100 on, Thursday, February 17th, 2022
